Combined Containment Level 3 Unit
Facilities and regulatory program for research with infectious biological agents that require high containment infrastructure and operational approaches
Leading Regulatory Program
The Faculty of Medicine maintains secure facilities for work with Risk Group 3 pathogens such that crucial research on established and emerging infectious diseases can be conducted while ensuring researchers and the larger community are protected from risk. Paramount in the support of these facilities is the regulatory group within the Faculty of Medicine that oversees and facilitates the work that is undertaken in the C-CL3 Unit. This team provides expert risk assessment for research projects, standardized protocol development and essential training and certification for all C-CL3 research personnel. Our approach meets and seeks to exceed all federal regulatory requirements and has been acknowledged as sector leading by national regulatory bodies.
The C-CL3 Unit is outfitted to support both in vivo and in vitro research programs, with all appropriate biocontainment and essential laboratory equipment in place. Additionally, the facilities offer the following preparatory and analytical equipment:
- Shaking incubators
- Hand held homogenizers
- EVOS and EVOS-FL microscopes for bright field and fluorescence imaging
- Plate washer and luminometer/fluorescence plate reader
- Glas-Col inhalation exposure system
The C-CL3 facilities and services are available for a fee for researchers from UofT, UHN and other academic institutions as well as industrial sector partners.
Please contact the C-CL3 team for more information.
Scott Gray-Owen, PhD
Natasha Christie-Holmes, PhD